MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-56-0035076
Mediflorence Medicaments Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.62 Cr
▲ 6% YoY
Net profit · FY 2025
₹3.25 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹10.98 Lakh
EBITDA margin 2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
4
As per MCA filings
About Mediflorence Medicaments Limited
Data last updated:
Mediflorence Medicaments Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2012PLC231292. Its GSTIN is 09AAICM4762C1ZF (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sunil Kumar Sharma and Vibhu Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 86 R Block Dilshad Garden, New Delhi, Delhi, India – 110095.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.62 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹3.25 Lakh (net margin 0.6%) and EBITDA of ₹10.98 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 13% over five years.
The company is associated with 1 brand: Mediflorence. As per MCA filings, the company has open charges of ₹20 Lakh on record.
Mediflorence Medicaments Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-56-0035076). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mediflorence.com.
Company details
CIN U24100DL2012PLC231292
Registration Number 231292
Incorporation Date 09 February 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-56-0035076
Recognitions & Rankings of Mediflorence Medicaments
Contact details
Mediflorence Medicaments Limited's registered office is in New Delhi, Delhi. Its website is mediflorence.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 86 R Block Dilshad Garden, New Delhi, Delhi, India – 110095
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mediflorence Medicaments Limited, buy the company report.
Comprehensive company report
Mediflorence Medicaments Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mediflorence Medicaments operates one associated brand: Mediflorence. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, marketing, and distribution of medicines in India. | mediflorence.com |
Business activity
The main business activity of Mediflorence Medicaments is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mediflorence Medicaments Limited, buy the company report.
Financials of Mediflorence Medicaments Limited
FY 2025 filings availableMediflorence Medicaments Limited reported revenue of ₹5.62 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹5.62 Cr ▲ 6%
Net profit · FY 2025
₹3.25 Lakh margin 0.6%
EBITDA · FY 2025
₹10.98 Lakh margin 2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 11%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 6%
5 years · compounded
▲ 3%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 6% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mediflorence Medicaments Limited, buy the company report.
Board of directors of Mediflorence Medicaments Limited
Mediflorence Medicaments has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Sharma | Director | 09 Feb 2012 | 14 Years 8 Months | Current |
| Vibhu Sharma | Director | 15 Mar 2021 | 5 Years 7 Months | Current |
| Nishant Agrawal | Director | 30 Sep 2013 | 13 Years 0 Months | Current |
| Bijender Kumar Jain Also directs: Integra Life Sciences Private Limited | Director | 09 Feb 2012 | 14 Years 8 Months | Current |
Auditor
Mediflorence Medicaments Limited is audited by HARISH CHANDRA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARISH CHANDRA & ASSOCIATES | FY 2021 | 006119C |
Shareholding
The shareholding of Mediflorence Medicaments Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Mediflorence Medicaments Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Nov 2017 | 100147793 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mediflorence Medicaments Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediflorence Medicaments Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mediflorence Medicaments has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICM4762C1ZF | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mediflorence Medicaments Limited, buy the company report.
Recent activity
Mediflorence Medicaments Limited has 7 board changes on record since 2012: 4 appointments and 3 cessations. The latest: Vibhu Sharma ceased to be Additional Director on 15 Nov 2021.
AGM
Mediflorence Medicaments Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mediflorence Medicaments Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Vibhu Sharma ceased to be Additional Director.
Ceased
Shivali Sharma ceased to be Director.
Appointed
Vibhu Sharma was appointed as Director.
Ceased
Sukhvinder Singh ceased to be Whole-Time Director.
Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 100147793 was registered on 08 Nov 2017.
Appointed
Nishant Agrawal was appointed as Director.
Appointed
Bijender Kumar Jain was appointed as Director.
Appointed
Sunil Kumar Sharma was appointed as Director.
Incorporation
09 Feb 2012
Mediflorence Medicaments Limited was registered on 09 Feb 2012 with Roc Delhi I & aged 14 years 8 months as per MCA records.
Frequently asked questions
Mediflorence Medicaments is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 February 2012 (14+ years old) and is registered under CIN U24100DL2012PLC231292.
Mediflorence Medicaments has 4 current directors:
- Sunil Kumar Sharma - Director
- Vibhu Sharma - Director
- Nishant Agrawal - Director
- Bijender Kumar Jain - Director
The latest financial statements of Mediflorence Medicaments on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mediflorence Medicaments is 09AAICM4762C1ZF, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Mediflorence Medicaments is U24100DL2012PLC231292. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediflorence Medicaments was incorporated on 09 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Vibhu Sharma ceased to be Additional Director on 15 Nov 2021. Shivali Sharma ceased to be Director on 15 Mar 2021. Vibhu Sharma was appointed as Director on 15 Mar 2021. Mediflorence Medicaments has 7 board changes on record in total.
Yes, Mediflorence Medicaments is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-56-0035076).
Mediflorence Medicaments can be reached through the website mediflorence.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Mediflorence Medicaments is at B – 86 R Block Dilshad Garden, New Delhi, Delhi, India – 110095.